Aurobindo Pharma launches kidney drug in the US
Aurobindo Pharma said it received final approval from the US Food & Drug Administration to manufacture generic version of kidney drug Renvela from Genzyme. Sevelamer Carbonate oral suspension, 0.8 gm and 2.4 gm is being launched immediately, the company said. The drug had a market size of US$140 million (Rs 900 cr) for the twelve […]